newsfilter
← Latest News
Business Wire·

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that as an inducement to entering into employment with the Company, on December 12, 2025, the Company's Board of Directors approved "inducement" grants to 78